NCI | Technology Transfer

Human Monoclonal Antibodies Specific For Glypican-3 And Use Thereof

Read more about Human Monoclonal Antibodies Specific For Glypican-3 And Use Thereof

Hong Kong
17102681.1
Filed on 2017-03-15

AGENTS AND METHODS TO ELICIT ANTI-TUMOR IMMUNE RESPONSE

Read more about AGENTS AND METHODS TO ELICIT ANTI-TUMOR IMMUNE RESPONSE

Sweden
07838099.5
Filed on 2007-09-13

AGENTS AND METHODS TO ELICIT ANTI-TUMOR IMMUNE RESPONSE

Read more about AGENTS AND METHODS TO ELICIT ANTI-TUMOR IMMUNE RESPONSE

The Netherlands
07838099.5
Filed on 2007-09-13

AGENTS AND METHODS TO ELICIT ANTI-TUMOR IMMUNE RESPONSE

Read more about AGENTS AND METHODS TO ELICIT ANTI-TUMOR IMMUNE RESPONSE

Italy
07838099.5
Filed on 2007-09-13

AGENTS AND METHODS TO ELICIT ANTI-TUMOR IMMUNE RESPONSE

Read more about AGENTS AND METHODS TO ELICIT ANTI-TUMOR IMMUNE RESPONSE

United Kingdom
07838099.5
Filed on 2007-09-13

AGENTS AND METHODS TO ELICIT ANTI-TUMOR IMMUNE RESPONSE

Read more about AGENTS AND METHODS TO ELICIT ANTI-TUMOR IMMUNE RESPONSE

France
07838099.5
Filed on 2007-09-13

AGENTS AND METHODS TO ELICIT ANTI-TUMOR IMMUNE RESPONSE

Read more about AGENTS AND METHODS TO ELICIT ANTI-TUMOR IMMUNE RESPONSE

Finland
07838099.5
Filed on 2007-09-13

AGENTS AND METHODS TO ELICIT ANTI-TUMOR IMMUNE RESPONSE

Read more about AGENTS AND METHODS TO ELICIT ANTI-TUMOR IMMUNE RESPONSE

Spain
07838099.5
Filed on 2007-09-13

AGENTS AND METHODS TO ELICIT ANTI-TUMOR IMMUNE RESPONSE

Read more about AGENTS AND METHODS TO ELICIT ANTI-TUMOR IMMUNE RESPONSE

Denmark
07838099.5
Filed on 2007-09-13

AGENTS AND METHODS TO ELICIT ANTI-TUMOR IMMUNE RESPONSE

Read more about AGENTS AND METHODS TO ELICIT ANTI-TUMOR IMMUNE RESPONSE

Germany
07838099.5
Filed on 2007-09-13

Subscribe to NCI